Physiological Roles of the Peptide Prokineticin 1

Total Page:16

File Type:pdf, Size:1020Kb

Physiological Roles of the Peptide Prokineticin 1 Physiological roles of the peptide Prokineticin 1 Thesis for the degree of Doctor of Philosophy Dr Ali Abbara MBBS BSc MRCP 2014 Department of Investigative Medicine Imperial College Abstract Prokineticin-1 (PK-1) and prokineticin-2 (PK-2) are two closely related cysteine-rich peptides which both bind to the prokineticin-1 and prokineticin-2 receptors (PKR-1 and PKR-2). The prokineticins were originally named due to their ability to stimulate gastrointestinal motility. Since that time, these peptides have been found to play a role in other biological processes including reproduction and nociception. Prokineticin-2 is known to be expressed in regions of the central nervous system involved in food intake. Consistent with this, work from our own department has shown that administration of prokineticin-2 to rodents reduces food intake both in lean and obese rodents. Prokineticin-2 is predominantly expressed within the central nervous system, whereas prokineticin-1 is heavily expressed in the gut. My pilot data showed that prokineticin 1 reduces food intake in rodents. I therefore hypothesised that prokineticin 1 may be a novel gut hormone. In this thesis, I investigate the role of prokineticin-1 on appetite in rodents and also compare the effects of prokineticin-1 with prokineticin-2. I also measured the changes in plasma levels of prokineticin in humans during feeding to establish the potential physiological relevance of prokineticin-1 as an anorectic gut hormone. Prokineticin-1 is also a potent angiogenic mitogen on endocrine vascular epithelium and hence it is also known as ‘Endocrine Gland-Vascular Endothelial Factor’. Placental angiogenesis plays an important role in placental function and risk of pregnancy complications such as miscarriage. I therefore hypothesised that prokineticin-1 is a biomarker of pregnancy complications in humans. In this thesis, I have measured circulating levels of prokineticin-1 found in pregnancy and correlated these with the occurrence of pregnancy complications. I have also compared the utility of prokineticin 1 with other potential novel markers of pregnancy complications. Together this body of work investigates the potential physiological roles of prokineticin-1. 2 Acknowledgements I would like to gratefully acknowledge Professor Waljit Dhillo and Dr Channa Jayasena for supervising me and supporting me throughout my PhD. I would also like to thank all members of our group for all their support and assistance with this work. I am also grateful to the Wellcome Trust for funding my Clinical Training Fellowship. 3 Declaration of contributors The majority of the work carried out in this thesis was performed by the author. All collaborations and assistance are described below: Chapter 2: Assistance with animal studies was provided by Dr Gardiner, Professor Dhillo and members of the hypothalamic group. Chapter 3: I would like to thank my colleagues Dr Izzi-Engbeaya, Ms Ganiyu-Dada for their help in collecting the pregnancy samples from the maternity unit. I would also like to thank my colleagues Dr Jayasena, Dr Comninos, Dr Sarang, Ms Malik, Dr Narayanaswamy, Ms Ng, Dr Buckley, for their help in carrying out the measurement of PK-1 and other pregnancy markers. In-house radioimmunoassay for the measurement of plasma kisspeptin used in this programme of research were established and maintained by Professor Mohammad Ghatei. The copyright of this thesis rests with the author and is made available under a Creative Commons Attribution Non-Commercial No Derivatives licence. Researchers are free to copy, distribute or transmit the thesis on the condition that they attribute it, that they do not use it for commercial purposes and that they do not alter, transform or build upon it. For any reuse or redistribution, researchers must make clear to others the licence terms of this work. Declaration signature Ali Abbara . 4 Table of Contents: Abstract ............................................................................................................................ 2 Acknowledgements ......................................................................................................... 3 Declaration of contributors .............................................................................................. 4 Abbreviations ................................................................................................................ 14 Chapter 1 ...................................................................................................................... 17 The obesity epidemic ..................................................................................................... 18 The Hypothalamus ......................................................................................................... 20 The Arcuate Nucleus (ARC) ......................................................................................... 23 The Paraventricular nucleus (PVN) ............................................................................... 25 The Lateral Hypothalamus (LH) ................................................................................... 26 The Ventromedial Nucleus (VMN) ............................................................................... 27 The Dorsomedial Nucleus (DMN) ................................................................................ 29 Circulating Factors which act within the hypothalamus to regulate food intake and body weight ............................................................................................................................. 30 Prokineticins- a potential novel regulator of appetite .................................................... 33 Prokineticins (PKs): novel hypothalamic regulators of appetite and placental angiogenesis .................................................................................................................... 41 Chapter 2 ...................................................................................................................... 43 Introduction ................................................................................................................... 44 Hypothesis ..................................................................................................................... 47 Aims .............................................................................................................................. 47 Material and methods .................................................................................................... 48 5 1. Effect of ICV administration of 15, 50, 150 pmol of PK-1 during Dark Phase in male Wistar rats ....................................................................................................................... 48 Materials ........................................................................................................................ 48 Rodent models ............................................................................................................... 48 2. Effect of ICV administration of 15, 150 and 1500 pmol PK-1 ................................. 50 3. Comparison of peripheral administration of IP PK-1 and PK-2 at doses of 20, 60 and 540 nmol/kg between 0-24hrs in male C57BL/6 mice. .................................................. 51 Materials ........................................................................................................................ 51 4. Effect of IP PK-1 7 nmol/kg for up to 1 hour in mice (n=6 per group). ................... 52 5. Determination of the effect of fasting on expression of PK-1 in the stomach of Fed and Fasted mice ..................................................................................................................... 53 Total RNA extraction .................................................................................................... 54 Reverse Transcription (RT) ........................................................................................... 56 6. Human plasma PK1 levels fed fasted ........................................................................ 58 Methods: Plasma PK-1 measurement by ELISA kit (ABNOVA) ................................ 61 Reconstitution of the human PK-1 standard: ................................................................. 61 Preparation of 0.01 M PBS wash buffer: ....................................................................... 62 1. Results: ...................................................................................................................... 63 2. Results: ...................................................................................................................... 65 3. Results: ...................................................................................................................... 67 4. Results: ...................................................................................................................... 71 5. Results: ...................................................................................................................... 74 6. Results: ...................................................................................................................... 76 6 Discussion: .................................................................................................................... 80 Chapter 3 ...................................................................................................................... 83 Introduction: .................................................................................................................
Recommended publications
  • Strategies to Increase ß-Cell Mass Expansion
    This electronic thesis or dissertation has been downloaded from the King’s Research Portal at https://kclpure.kcl.ac.uk/portal/ Strategies to increase -cell mass expansion Drynda, Robert Lech Awarding institution: King's College London The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without proper acknowledgement. END USER LICENCE AGREEMENT Unless another licence is stated on the immediately following page this work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ You are free to copy, distribute and transmit the work Under the following conditions: Attribution: You must attribute the work in the manner specified by the author (but not in any way that suggests that they endorse you or your use of the work). Non Commercial: You may not use this work for commercial purposes. No Derivative Works - You may not alter, transform, or build upon this work. Any of these conditions can be waived if you receive permission from the author. Your fair dealings and other rights are in no way affected by the above. Take down policy If you believe that this document breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 Strategies to increase β-cell mass expansion A thesis submitted by Robert Drynda For the degree of Doctor of Philosophy from King’s College London Diabetes Research Group Division of Diabetes & Nutritional Sciences Faculty of Life Sciences & Medicine King’s College London 2017 Table of contents Table of contents .................................................................................................
    [Show full text]
  • Searching for Novel Peptide Hormones in the Human Genome Olivier Mirabeau
    Searching for novel peptide hormones in the human genome Olivier Mirabeau To cite this version: Olivier Mirabeau. Searching for novel peptide hormones in the human genome. Life Sciences [q-bio]. Université Montpellier II - Sciences et Techniques du Languedoc, 2008. English. tel-00340710 HAL Id: tel-00340710 https://tel.archives-ouvertes.fr/tel-00340710 Submitted on 21 Nov 2008 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITE MONTPELLIER II SCIENCES ET TECHNIQUES DU LANGUEDOC THESE pour obtenir le grade de DOCTEUR DE L'UNIVERSITE MONTPELLIER II Discipline : Biologie Informatique Ecole Doctorale : Sciences chimiques et biologiques pour la santé Formation doctorale : Biologie-Santé Recherche de nouvelles hormones peptidiques codées par le génome humain par Olivier Mirabeau présentée et soutenue publiquement le 30 janvier 2008 JURY M. Hubert Vaudry Rapporteur M. Jean-Philippe Vert Rapporteur Mme Nadia Rosenthal Examinatrice M. Jean Martinez Président M. Olivier Gascuel Directeur M. Cornelius Gross Examinateur Résumé Résumé Cette thèse porte sur la découverte de gènes humains non caractérisés codant pour des précurseurs à hormones peptidiques. Les hormones peptidiques (PH) ont un rôle important dans la plupart des processus physiologiques du corps humain.
    [Show full text]
  • Placental Growth Hormone-Related Proteins and Prolactin-Related Proteins
    Placental Growth Hormone-Related Proteins and Prolactin-Related Proteins The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Haig, D. 2008. Placental growth hormone-related proteins and prolactin-related proteins. Placenta 29: 36-41. Published Version doi:10.1016/j.placenta.2007.09.010 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11148777 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Placental growth hormone-related proteins and prolactin-related proteins. David Haig Department of Organismic and Evolutionary Biology, Harvard University, 26 Oxford Street, Cambridge MA 02138. e-mail: [email protected] phone: 617-496-5125 fax: 617-495-5667 Keywords: GH, PRL, placenta, endometrial glands, placental lactogen The placentas of ruminants and muroid rodents express prolactin (PRL)-related genes whereas the placentas of anthropoid primates express growth hormone (GH)-related genes. The evolution of placental expression is associated with acclerated evolution of the corresponding pituitary hormone and destabilization of conserved endocrine systems. In particular, placental hormones often evolve novel interactions with new receptors. The adaptive functions of some placental hormones may be revealed only under conditions of physiological stress. Introduction Placental hormones are produced by offspring, but act on receptors of mothers. As such, placental hormones and maternal receptors are prime candidates for the expression of parent-offspring conflict [1,2].
    [Show full text]
  • Pathophysiology of Gestational Diabetes Mellitus: the Past, the Present and the Future
    6 Pathophysiology of Gestational Diabetes Mellitus: The Past, the Present and the Future Mohammed Chyad Al-Noaemi1 and Mohammed Helmy Faris Shalayel2 1Al-Yarmouk College, Khartoum, 2National College for Medical and Technical Studies, Khartoum, Sudan 1. Introduction It is just to remember that “Pathophysiology” refers to the study of alterations in normal body function (physiology and biochemistry) which result in disease. E.g. changes in the normal thyroid hormone level causes either hyper or hypothyroidism. Changes in insulin level as a decrease in its blood level or a decrease in its action will cause hyperglycemia and finally diabetes mellitus. Scientists agreed that gestational diabetes mellitus (GDM) is a condition in which women without previously diagnosed diabetes exhibit high blood glucose levels during pregnancy. From our experience most women with GDM in the developing countries are not aware of the symptoms (i.e., the disease will be symptomless). While some of the women will have few symptoms and their GDM is most commonly diagnosed by routine blood examinations during pregnancy which detect inappropriate high level of glucose in their blood samples. GDM should be confirmed by doing fasting blood glucose and oral glucose tolerance test (OGTT), according to the WHO diagnostic criteria for diabetes. A decrease in insulin sensitivity (i.e. an increase in insulin resistance) is normally seen during pregnancy to spare the glucose for the fetus. This is attributed to the effects of placental hormones. In a few women the physiological changes during pregnancy result in impaired glucose tolerance which might develop diabetes mellitus (GDM). The prevalence of GDM ranges from 1% to 14% of all pregnancies depending on the population studied and the diagnostic tests used.
    [Show full text]
  • Deletion of Vax1 from Gonadotropin-Releasing Hormone (Gnrh) Neurons Abolishes Gnrh Expression and Leads to Hypogonadism and Infertility
    3506 • The Journal of Neuroscience, March 23, 2016 • 36(12):3506–3518 Cellular/Molecular Deletion of Vax1 from Gonadotropin-Releasing Hormone (GnRH) Neurons Abolishes GnRH Expression and Leads to Hypogonadism and Infertility Hanne M. Hoffmann,1 Crystal Trang,1 Ping Gong,1 Ikuo Kimura,2 Erica C. Pandolfi,1 and XPamela L. Mellon1 1Department of Reproductive Medicine and the Center for Reproductive Science and Medicine, University of California, San Diego, La Jolla, California 92093-0674, and 2Department of Applied Biological Science, Graduate School of Agriculture, Tokyo University of Agriculture and Technology, Fuchu-shi 183-8509, Japan Hypothalamic gonadotropin-releasing hormone (GnRH) neurons are at the apex of the hypothalamic-pituitary-gonadal axis that regu- lates mammalian fertility. Herein we demonstrate a critical role for the homeodomain transcription factor ventral anterior homeobox 1 (VAX1) in GnRH neuron maturation and show that Vax1 deletion from GnRH neurons leads to complete infertility in males and females. Specifically, global Vax1 knock-out embryos had normal numbers of GnRH neurons at 13 d of gestation, but no GnRH staining was detected by embryonic day 17. To identify the role of VAX1 specifically in GnRH neuron development, Vax1flox mice were generated and lineage tracing performed in Vax1flox/flox:GnRHcre:RosaLacZ mice. This identified VAX1 as essential for maintaining expression of Gnrh1. The absence of GnRH staining in adult Vax1flox/flox:GnRHcre mice led to delayed puberty, hypogonadism, and infertility. To address the mechanism by which VAX1 maintains Gnrh1 transcription, the capacity of VAX1 to regulate Gnrh1 transcription was evaluated in the GnRH cell lines GN11 and GT1-7.
    [Show full text]
  • Loss-Of-Function Mutation in the Prokineticin 2 Gene Causes
    Loss-of-function mutation in the prokineticin 2 gene SEE COMMENTARY causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism Nelly Pitteloud*†, Chengkang Zhang‡, Duarte Pignatelli§, Jia-Da Li‡, Taneli Raivio*, Lindsay W. Cole*, Lacey Plummer*, Elka E. Jacobson-Dickman*, Pamela L. Mellon¶, Qun-Yong Zhou‡, and William F. Crowley, Jr.* *Reproductive Endocrine Unit, Department of Medicine and Harvard Reproductive Endocrine Science Centers, Massachusetts General Hospital, Boston, MA 02114; ‡Department of Pharmacology, University of California, Irvine, CA 92697; §Department of Endocrinology, Laboratory of Cellular and Molecular Biology, Institute of Molecular Pathology and Immunology, University of Porto, San Joa˜o Hospital, 4200-465 Porto, Portugal; and ¶Departments of Reproductive Medicine and Neurosciences, University of California at San Diego, La Jolla, CA 92093 Communicated by Patricia K. Donahoe, Massachusetts General Hospital, Boston, MA, August 14, 2007 (received for review May 8, 2007) Gonadotropin-releasing hormone (GnRH) deficiency in the human associated with KS, although no functional data on the mutant presents either as normosmic idiopathic hypogonadotropic hypo- proteins were provided (17). Herein, we demonstrate that homozy- gonadism (nIHH) or with anosmia [Kallmann syndrome (KS)]. To gous loss-of-function mutations in the PROK2 gene cause IHH in date, several loci have been identified to cause these disorders, but mice and humans. only 30% of cases exhibit mutations in known genes. Recently, murine studies have demonstrated a critical role of the prokineticin Results pathway in olfactory bulb morphogenesis and GnRH secretion. Molecular Analysis of PROK2 Gene. A homozygous single base pair Therefore, we hypothesize that mutations in prokineticin 2 deletion in exon 2 of the PROK2 gene (c.[163delA]ϩ [163delA]) (PROK2) underlie some cases of KS in humans and that animals was identified in the proband, in his brother with KS, and in his deficient in Prok2 would be hypogonadotropic.
    [Show full text]
  • Signaling Role of Prokineticin 2 on the Estrous Cycle of Female Mice
    Signaling Role of Prokineticin 2 on the Estrous Cycle of Female Mice The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Xiao, Ling, Chengkang Zhang, Xiaohan Li, Shiaoching Gong, Renming Hu, Ravikumar Balasubramanian, William F. Crowley W. Jr., Michael H. Hastings, and Qun-Yong Zhou. 2014. “Signaling Role of Prokineticin 2 on the Estrous Cycle of Female Mice.” PLoS ONE 9 (3): e90860. doi:10.1371/journal.pone.0090860. http:// dx.doi.org/10.1371/journal.pone.0090860. Published Version doi:10.1371/journal.pone.0090860 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:12064464 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Signaling Role of Prokineticin 2 on the Estrous Cycle of Female Mice Ling Xiao1,2, Chengkang Zhang1, Xiaohan Li1, Shiaoching Gong3, Renming Hu4, Ravikumar Balasubramanian5, William F. Crowley W. Jr.5, Michael H. Hastings6, Qun-Yong Zhou1* 1 Department of Pharmacology, University of California, Irvine, California, United States of America, 2 Department of Endocrinology, Jinshan Hospital affiliated to Fudan University, Shanghai, China, 3 GENSAT Project, The Rockefeller University, New York, New York, United States of America, 4 Institute of Endocrinology and Diabetology, Huashan Hospital affiliated to Fudan University, Shanghai, China, 5 Harvard Reproductive Endocrine Sciences Center & The Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, United States of America, 6 Division of Neurobiology, Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom Abstract The possible signaling role of prokineticin 2 (PK2) and its receptor, prokineticin receptor 2 (PKR2), on female reproduction was investigated.
    [Show full text]
  • Orphan G Protein-Coupled Receptors and Obesity
    European Journal of Pharmacology 500 (2004) 243–253 www.elsevier.com/locate/ejphar Review Orphan G protein-coupled receptors and obesity Yan-Ling Xua, Valerie R. Jacksonb, Olivier Civellia,b,* aDepartment of Pharmacology, University of California Irvine, 101 Theory Dr., Suite 200, Irvine, CA 92612, USA bDepartment of Developmental and Cell Biology, University of California Irvine, 101 Theory Dr, Irvine, CA 92612, USA Accepted 1 July 2004 Available online 19 August 2004 Abstract The use of orphan G protein-coupled receptors (GPCRs) as targets to identify new transmitters has led over the last decade to the discovery of 12 novel neuropeptide families. Each one of these new neuropeptides has opened its own field of research, has brought new insights in distinct pathophysiological conditions and has offered new potentials for therapeutic applications. Interestingly, several of these novel peptides have seen their roles converge on one physiological response: the regulation of food intake and energy expenditure. In this manuscript, we discuss four deorphanized GPCR systems, the ghrelin, orexins/hypocretins, melanin-concentrating hormone (MCH) and neuropeptide B/neuropeptide W (NPB/NPW) systems, and review our knowledge of their role in the regulation of energy balance and of their potential use in therapies directed at feeding disorders. D 2004 Elsevier B.V. All rights reserved. Keywords: Feeding; Ghrelin; Orexin/hypocretin; Melanin-concentrating hormone; Neuropeptide B; Neuropeptide W Contents 1. Introduction............................................................ 244 2. Searching for the natural ligands of orphan GPCRs ....................................... 244 2.1. Reverse pharmacology .................................................. 244 2.2. Orphan receptor strategy ................................................. 244 3. Orphan receptors and obesity................................................... 245 3.1. The ghrelin system .................................................... 245 3.2.
    [Show full text]
  • (PROK2) in Alzheimer's Disease
    cells Communication Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology Roberta Lattanzi 1, Daniela Maftei 1, Carla Petrella 2, Massimo Pieri 3, Giulia Sancesario 4, Tommaso Schirinzi 5, Sergio Bernardini 3, Christian Barbato 2 , Massimo Ralli 6 , Antonio Greco 6, Roberta Possenti 5, Giuseppe Sancesario 5 and Cinzia Severini 2,* 1 Department of Physiology and Pharmacology “Vittorio Erspamer”, Sapienza University of Rome, P.za A. Moro 5, 00185 Rome, Italy; [email protected] (R.L.); [email protected] (D.M.) 2 Institute of Biochemistry and Cell Biology, IBBC, CNR, Viale del Policlinico, 155, 00161 Rome, Italy; [email protected] (C.P.); [email protected] (C.B.) 3 Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, 00133 Rome, Italy; [email protected] (M.P.); [email protected] (S.B.) 4 Neuroimmunology Unit, IRCCS Santa Lucia Foundation, v. Ardeatina 354, 00179 Rome, Italy; [email protected] 5 Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy; [email protected] (T.S.); [email protected] (R.P.); [email protected] (G.S.) 6 Department of Sense Organs, University Sapienza of Rome, Viale del Policlinico 155, 00161 Rome, Italy; [email protected] (M.R.); [email protected] (A.G.) * Correspondence: [email protected]; Tel.: +39-06-4997-6742 Received: 17 October 2019; Accepted: 12 November 2019; Published: 13 November 2019 Abstract: Among mediators of inflammation, chemokines play a pivotal role in the neuroinflammatory process related to Alzheimer’s disease (AD).
    [Show full text]
  • Fetal Growth Signals
    Arch Dis Child: first published as 10.1136/adc.64.1_Spec_No.53 on 1 January 1989. Downloaded from Archives of Disease in Childhood, 1989, 64, 53-57 Current topic Fetal growth signals R D G MILNER AND D J HILL Department of Paediatrics, Children's Hospital, Sheffield Human fetal growth is not uniform. Tissue patterns growth factor fi like peptide is found in the vegetal and organ primordia are established during embryo- pole ectoderm of the early Xenopus embryo and is genesis, then from the end of the first trimester and transcribed by a maternally derived gene designated throughout the second the fetus undergoes massive Vgl. An ectodermal cell line, XTC, from the meta- hyperplasia. In the third trimester further organ morphosing tadpole releases a transforming growth modelling and functional maturation occur in pre- factor I8 like peptide in vitro.5 In the 11-18 day fetal paration for extrauterine life. Each aspect ofdevelop- mouse transforming growth factor 3 can be detected ment requires orchestrated intercellular signalling at in bone and connective tissue, particularly that two levels. The release of peptide growth factors derived from neural crest such as palate, larynx, and the modulation of an extracellular matrix are facial mesenchyme, and teeth.6 Staining was most paracrine actions that occur within cell populations intense at sites of tissue morphogenesis affecting and between adjacent germ layers. In contrast, mesodermal and epithelial interaction such as hair endocrine hormones may stimulate growth non- follicles, teeth, and secondary palate. copyright. specifically or promote specific maturational events. Recently both fibroblast growth factor and trans- The interactions between paracrinology, endocrino- forming growth factor i have been shown to exert logy, and environmental constraints to growth remarkable effects on embryonal morphology.
    [Show full text]
  • ACTIVIN IS CRITICAL for the DEVELOPMENT of PAIN HYPERSENSITIVITY AFTER INFLAMMATION by PIN XU Submitted in Partial Fulfillment
    ACTIVIN IS CRITICAL FOR THE DEVELOPMENT OF PAIN HYPERSENSITIVITY AFTER INFLAMMATION by PIN XU Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Thesis Adviser: Dr. Alison K. Hall Department of Neurosciences CASE WESTERN RESERVE UNIVERSITY August, 2007 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of ____Pin Xu______________________________________________ candidate for the Ph.D. degree *. (signed)__ Gary Landreth______________________________ ___ (chair of the committee) ___Alison Hall____________________________________ ___Jerry Silver___________ ___________ _____ ___ ___Susann Brady-kalnay____________________________ ________________________________________________ ________________________________________________ (date) ____June 5, 2007___________________ *We also certify that written approval has been obtained for any proprietary material contained therein. ii DEDICATION This thesis is dedicated to my parents, Hongfa Xu and Ruiyun Pan, and to my husband Chen Liu. iii TABLE OF CONTENTS Page Title Page……………………..…………………………………………………….….…I Typed ETD Sign-off Sheet…………………………………………………….................II Dedication……………………………………………………………………………..…III Table of Contents………………………………………………………..……..……..….IV List of Tables……………………………………………………………………………VII List of Figures…………………………………………………………………….....…VIII Acknowledgements………………………………………………………………………X Abstract…………………………………………………………………………...……...XI Chapter I: General Introduction……………………………………………………………………...1 Chapter
    [Show full text]
  • The Endocrine Function of the Placenta: Interactions Between Trophic Peptides and Hormones
    Placenlal Function and Fetal Nutrition, edited by Frederick C. Battaglia, Nestle Nutrition Workshop Series. Vol. 39. Nestec Ltd.. Vevey/Lippincott-Raven Publishers. Philadelphia. © 1997. The Endocrine Function of the Placenta: Interactions Between Trophic Peptides and Hormones Lise Cedard U. 361 INSERM, Maternite Baudelocque, 121 Boulevard de Port-Royal Paris, France The placenta is classically considered to be a source of hormones that play an important role in the establishment and maintenance of pregnancy. Because of its hemochorial structure, the human placenta produces hormones and easily secretes them into the maternal circulation. They include steroid hormones, such as estrogens and progesterone, and protein hormones, the most important of which are the chori- onic gonadotrophins (hCG), discovered in 1927. During the period from 1960 to 1980, the concept of a fetoplacental unit (1) with a complementary role for the fetus in steroid production offered a new approach to steroid metabolism, and since then new proteins and neuropeptides have been discovered (2,3). However, the lack of innervation of placental tissue highlights the importance of understanding neuroen- docrine regulation of placental physiology. Sophisticated culture methods enabling the study of biologic phenomena occurring during transformation of cytotrophoblast cells into a syncytiotrophoblast (4) have been combined with electron microscopy and histochemistry. Possibilities offered by molecular biology, including in situ hybridization and molecular cloning studies,
    [Show full text]